Eli Lilly (NYSE:LLY) recently announced several significant events, including promising trial results for baricitinib in ...

"Billionaire" and "successful hedge fund manager" are titles that carry significant weight on Wall Street. These and others ...

We recently published a list of 12 Best Quality Stocks to Invest in Now. In this article, we are going to take a look at ...

As the potential of GLP-1 agonists for addiction gains traction, big pharma is also starting to take notice, namely the two ...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...

From novel pharmaceuticals to telemedicine ... quality of medicines available at the time, Eli Lilly (NYSE:LLY) discovers, ...

Biolexis Therapeutics has achieved a transformative milestone in metabolic drug discovery with the successful resolution of the cryo-electron microscopy (cryoEM) structure of BLX-7006, its ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for ...

Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now ...